Graves’ ophthalmopathy: State of the art and perspectives
Authors:
- 18 March 2004
- journal article
- review article
- Published by Springer Nature in Journal of Endocrinological Investigation
- Vol. 27 (3) , 295-301
Abstract
Graves’ ophthalmopathy (GO) is an autoimmune orbital disorder most commonly associated with Graves’ disease. Recent studies have underscored the role that orbital cells, particularly fibroblasts and adipocytes, play in causing the increase in orbital content responsible for clinical manifestations of the disease. GO seems to be related to autoimmune reactions triggered by autoreactive T lymphocytes of thyroid origin, which recognize antigen(s) shared by thyroid and orbit. The nature of the antigen (or antigens) involved is not fully understood, but TSH receptor is likely to be involved. Cytokines secreted by T lymphocytes, macrophages and fibroblasts play an essential role in perpetuating the disease. Animal models of GO have been developed, but results have not clarified GO pathogenesis yet. Progress in the management of the ophthalmopathy has been very limited, and glucocorticoids, orbital radiotherapy and orbital decompression remain the mainstays in GO treatment. Novel treatments, such as somatostatin analogues, antioxidants, cytokine antagonists are currently under investigation, as well as the effects of total thyroid ablation. Cessation of smoking currently represents the only form of GO (secondary and tertiary) prevention.Keywords
This publication has 61 references indexed in Scilit:
- Oxidative stress and Graves' ophthalmopathy: In vitro studies and therapeutic implicationsBioFactors, 2003
- Thyroglobulin in Orbital Tissues from Patients with Thyroid-Associated Ophthalmopathy: Predominant Localization in Fibroadipose TissueThyroid®, 2002
- A role for methotrexate in the management of non-infectious orbital inflammatory diseaseBritish Journal of Ophthalmology, 2001
- Identification of Thyroglobulin in Orbital Tissues of Patients with Thyroid-Associated OphthalmopathyThyroid®, 2001
- Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosisThe Lancet, 1999
- Superoxide Radical Production Stimulates Retroocular Fibroblast Proliferation in Graves' OphthalmopathyExperimental Eye Research, 1997
- Detection and localization of cytokine immunoreactivity in retro‐ocular connective tissue in Graves' opthalmopathyEuropean Journal of Clinical Investigation, 1993
- Nicotinamide and 3‐aminobenzamide inhibit recombinant human interferon‐γ‐induced HLA‐DR antigen expression, but not HLA‐A, B, C antigen expression, on cultured human thyroid cellsClinical Endocrinology, 1992
- Prednisone and Cyclosporine in the Treatment of Severe Graves' OphthalmopathyNew England Journal of Medicine, 1989
- Differing responses of inbred rat strains in experimental autoimmune thyroiditisCellular Immunology, 1975